Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

74 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Heart failure.
Jessup M, Brozena S. Jessup M, et al. Among authors: brozena s. N Engl J Med. 2003 May 15;348(20):2007-18. doi: 10.1056/NEJMra021498. N Engl J Med. 2003. PMID: 12748317 Review. No abstract available.
Immunogenicity of pneumococcal vaccine in heart transplant recipients.
Blumberg EA, Brozena SC, Stutman P, Wood D, Phan HM, Musher DM. Blumberg EA, et al. Among authors: brozena sc. Clin Infect Dis. 2001 Jan 15;32(2):307-10. doi: 10.1086/318482. Epub 2000 Dec 22. Clin Infect Dis. 2001. PMID: 11170924
Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Database.
Costanzo MR, Naftel DC, Pritzker MR, Heilman JK 3rd, Boehmer JP, Brozena SC, Dec GW, Ventura HO, Kirklin JK, Bourge RC, Miller LW. Costanzo MR, et al. Among authors: brozena sc. J Heart Lung Transplant. 1998 Aug;17(8):744-53. J Heart Lung Transplant. 1998. PMID: 9730422
Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET).
Massie BM, Berk MR, Brozena SC, Elkayam U, Plehn JF, Kukin ML, Packer M, Murphy BE, Neuberg GW, Steingart RM, et al. Massie BM, et al. Among authors: brozena sc. Circulation. 1993 Aug;88(2):492-501. doi: 10.1161/01.cir.88.2.492. Circulation. 1993. PMID: 8339411 Clinical Trial.
Efficacy of phosphodiesterase inhibition with milrinone in combination with converting enzyme inhibitors in patients with heart failure. The Milrinone Multicenter Trials Investigators.
Colucci WS, Sonnenblick EH, Adams KF, Berk M, Brozena SC, Cowley AJ, Grabicki JM, Kubo SA, LeJemtel T, Littler WA, et al. Colucci WS, et al. Among authors: brozena sc. J Am Coll Cardiol. 1993 Oct;22(4 Suppl A):113A-118A. doi: 10.1016/0735-1097(93)90473-e. J Am Coll Cardiol. 1993. PMID: 8376682 Clinical Trial.
Effectiveness and safety of diltiazem or lisinopril in treatment of hypertension after heart transplantation. Results of a prospective, randomized multicenter trail.
Brozena SC, Johnson MR, Ventura H, Hobbs R, Miller L, Olivari MT, Clemson B, Bourge R, Quigg R, Mills RM Jr, Naftel D. Brozena SC, et al. J Am Coll Cardiol. 1996 Jun;27(7):1707-12. doi: 10.1016/0735-1097(96)00057-5. J Am Coll Cardiol. 1996. PMID: 8636558 Clinical Trial.
Identification and management of potential heart transplant recipients.
Jessup M, Brozena SC. Jessup M, et al. Among authors: brozena sc. Cardiol Clin. 1990 Feb;8(1):11-21. Cardiol Clin. 1990. PMID: 2407353 Review.
Steady-state pharmacokinetics of carvedilol and its enantiomers in patients with congestive heart failure.
Tenero D, Boike S, Boyle D, Ilson B, Fesniak HF, Brozena S, Jorkasky D. Tenero D, et al. Among authors: brozena s. J Clin Pharmacol. 2000 Aug;40(8):844-53. doi: 10.1177/00912700022009576. J Clin Pharmacol. 2000. PMID: 10934668
New approaches in the management of patients with chronic congestive heart failure.
Jessup M, Brozena S. Jessup M, et al. Among authors: brozena s. Drugs Today (Barc). 1999 Nov;35(11):849-55. doi: 10.1358/dot.1999.35.11.562558. Drugs Today (Barc). 1999. PMID: 12973376
Pathophysiologic strategies in the management of congestive heart failure.
Brozena S, Jessup M. Brozena S, et al. Annu Rev Med. 1990;41:65-74. doi: 10.1146/annurev.me.41.020190.000433. Annu Rev Med. 1990. PMID: 2184749 Review.
74 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback